loadpatents
Patent applications and USPTO patent grants for Helal; Christopher John.The latest application filed is for "novel imidazo[4,5-c]quinoline derivatives as lrrk2 inhibitors".
Patent | Date |
---|---|
Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors Grant 11,312,713 - Brodney , et al. April 26, 2 | 2022-04-26 |
Novel Imidazo[4,5-c]quinoline Derivatives As Lrrk2 Inhibitors App 20210355117 - BRODNEY; Michael Aaron ;   et al. | 2021-11-18 |
Cyclic substituted imidazo[4,5-c]quinoline derivatives Grant 11,161,844 - Chappie , et al. November 2, 2 | 2021-11-02 |
Piperazine Azaspiro Derivaves App 20210024497 - Zhang; Lei ;   et al. | 2021-01-28 |
Heterocyclic spiro compounds as MAGL inhibitors Grant 10,858,373 - Brodney , et al. December 8, 2 | 2020-12-08 |
6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds Grant 10,738,063 - Chappie , et al. A | 2020-08-11 |
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors Grant 10,723,711 - Butler , et al. | 2020-07-28 |
Imidazopyridazine compounds Grant 10,669,279 - Chappie , et al. | 2020-06-02 |
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL inhibitors Grant 10,626,125 - Brodney , et al. | 2020-04-21 |
Cyclic Substituted Imidazo[4,5-c]quinoline Derivatives App 20200039977 - Chappie; Thomas Allen ;   et al. | 2020-02-06 |
1,1,1-trifluoro-3-hydroxypropan-2-yl Carbamate Derivatives And 1,1,1-trifluoro-4-hydroxybutan-2-yl Carbamate Derivatives As Magl App 20190382359 - BUTLER; CHRISTOPHER RYAN ;   et al. | 2019-12-19 |
Imidazopyridazine Compounds App 20190322674 - Chappie; Thomas Allen ;   et al. | 2019-10-24 |
6,7-dihydro-5h-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide Compounds App 20190300546 - Chappie; Thomas Allen ;   et al. | 2019-10-03 |
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors Grant 10,428,034 - Butler , et al. October 1, 2 | 2019-10-01 |
1,1,1-trifluoro-3-hydroxypropan-2-yl Carbamate Derivatives As Magl Inhibitors App 20190276472 - BRODNEY; MICHAEL AARON ;   et al. | 2019-09-12 |
Tricyclic Compounds And Their Use As Phosphodiesterase Inhibitors App 20190263816 - Chappie; Thomas Allen ;   et al. | 2019-08-29 |
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL inhibitors Grant 10,329,308 - Brodney , et al. | 2019-06-25 |
6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds Grant 10,323,042 - Chappie , et al. | 2019-06-18 |
6,7-dihydro-5h-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide Compounds App 20190055262 - Chappie; Thomas Allen ;   et al. | 2019-02-21 |
Imidazopyridazine Compounds App 20180346475 - Chappie; Thomas Allen ;   et al. | 2018-12-06 |
Pyrazolopyrimidine compounds Grant 10,131,669 - Chappie , et al. November 20, 2 | 2018-11-20 |
Imidazopyridazine compounds Grant 10,077,269 - Chappie , et al. September 18, 2 | 2018-09-18 |
1,1,1-trifluoro-3-hydroxypropan-2-yl Carbamate Derivatives As Magl Inhibitors App 20180208607 - BRODNEY; MICHAEL AARON ;   et al. | 2018-07-26 |
Heterocyclic Spiro Compounds As Magl Inhibitors App 20180208608 - BRODNEY; MICHAEL AARON ;   et al. | 2018-07-26 |
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands App 20180200253 - COE; JOTHAM WADSWORTH ;   et al. | 2018-07-19 |
1,1,1-trifluoro-3-hydroxypropan-2-yl Carbamate Derivatives And 1,1,1-trifluoro-4-hydroxybutan-2-yl Carbamate Derivatives As Magl Inhibitors App 20180065943 - BUTLER; CHRISTOPHER RYAN ;   et al. | 2018-03-08 |
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors Grant 9,845,301 - Butler , et al. December 19, 2 | 2017-12-19 |
Pyrazolopyrimidine Compounds App 20170204099 - Chappie; Thomas Allen ;   et al. | 2017-07-20 |
Imidazopyridazine Compounds App 20170145022 - Chappie; Thomas Allen ;   et al. | 2017-05-25 |
Imidazopyridazine compounds Grant 9,598,421 - Chappie , et al. March 21, 2 | 2017-03-21 |
1,1,1-trifluoro-3-hydroxypropan-2-yl Carbamate Derivatives And 1,1,1-trifluoro-4-hydroxybutan-2-yl Carbamate Derivatives As Magl Inhibitors App 20170029390 - BUTLER; CHRISTOPHER RYAN ;   et al. | 2017-02-02 |
Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds Grant 9,550,795 - Brodney , et al. January 24, 2 | 2017-01-24 |
Triazine derivatives Grant 9,296,761 - Chappie , et al. March 29, 2 | 2016-03-29 |
Imidazopyridazine Compounds App 20160039828 - Chappie; Thomas Allen ;   et al. | 2016-02-11 |
Triazine Derivatives App 20150353579 - Chappie; Thomas Allen ;   et al. | 2015-12-10 |
Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders Grant 9,200,000 - Helal , et al. December 1, 2 | 2015-12-01 |
Triazine derivatives Grant 9,145,427 - Chappie , et al. September 29, 2 | 2015-09-29 |
Hexahydropyrano[3,4-d][1,3]Thiazin-2-Amine Compounds App 20150087637 - Brodney; Michael Aaron ;   et al. | 2015-03-26 |
Triazine Derivatives App 20150080401 - Chappie; Thomas Allen ;   et al. | 2015-03-19 |
Triazine derivatives Grant 8,933,224 - Chappie , et al. January 13, 2 | 2015-01-13 |
Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds Grant 8,933,221 - Brodney , et al. January 13, 2 | 2015-01-13 |
Triazine Derivatives App 20140329820 - Chappie; Thomas Allen ;   et al. | 2014-11-06 |
Pyrazolo[3,4-d]pyrimidine compounds and their use as PDE2 inhibitors and/or CYP3A4 inhibitors Grant 8,829,010 - Helal , et al. September 9, 2 | 2014-09-09 |
Amino-Heterocyclic Compounds App 20140088081 - Claffey; Michelle Marie ;   et al. | 2014-03-27 |
Pyrazolo[3,4-d]pyrimidine Compounds And Their Use As Pde2 Inhibitors And/or Cyp3a4 Inhibitors App 20140080806 - Helal; Christopher John ;   et al. | 2014-03-20 |
Imidazo[5,1-f][1,2,4]Triazines For The Treatment of Neurological Disorders App 20140066622 - Helal; Christopher John ;   et al. | 2014-03-06 |
Amino-heterocyclic compounds Grant 08618117 - | 2013-12-31 |
Amino-heterocyclic compounds Grant 8,618,117 - Claffey , et al. December 31, 2 | 2013-12-31 |
Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders Grant 8,598,155 - Helal , et al. December 3, 2 | 2013-12-03 |
Novel Sultam Compounds App 20130150376 - Brodney; Michael Aaron ;   et al. | 2013-06-13 |
Hexahydropyrano[3,4-d][1,3]Thiazin-2-Amine Compounds App 20130053373 - BRODNEY; Michael Aaron ;   et al. | 2013-02-28 |
Amino-Heterocyclic Compounds App 20120329777 - Claffey; Michelle Marie ;   et al. | 2012-12-27 |
Imidazo[5,1-f][1,2,4]Triazines for the Treatment of Neurological Disorders App 20120214791 - HELAL; Christopher John ;   et al. | 2012-08-23 |
11C-labeled benzyl-lactam compounds and their use as imaging agents Grant 8,012,969 - Helal , et al. September 6, 2 | 2011-09-06 |
Benzyl(idene)-lactam derivatives Grant 7,479,559 - Brodney , et al. January 20, 2 | 2009-01-20 |
11C-Labeled Benzyl-Lactam Compounds and Their Use as Imaging Agents App 20080206137 - Helal; Christopher John ;   et al. | 2008-08-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.